Leoutsakos v. Coll’s Hospital Pharm.

2003 DNH 109
District Court, D. New Hampshire·Decided July 8, 2003·No. CV-02-434-M·Published

Opinion

Leoutsakos v . Coll’s Hospital Pharm. CV-02-434-M 07/08/03 UNITED STATES DISTRICT COURT

DISTRICT OF NEW HAMPSHIRE

Thomas Leoutsakos, Plaintiff

v. Civil N o . 02-434-M Opinion N o . 2003 DNH 109 Coll’s Hospital Pharmacy, Inc. and HealthCraft Products, Inc., Defendants

O R D E R

Thomas Leoutsakos holds United States patent 5,195,200 (the “‘200 patent”), covering a “manual support apparatus attachable to a bedframe.” He claims that Coll’s Hospital Pharmacy, Inc., and HealthCraft Products, Inc., (“defendants”) have infringed that patent. Before the court are defendants’ motion for summary judgment (document n o . 1 5 ) , to which plaintiff has filed no objection, and plaintiff’s motion for summary judgment (document n o . 16). 1 Defendants’ motion for summary judgment is granted and plaintiff’s motion for summary judgment is denied.

1 Plaintiff has captioned his motion as one for partial summary judgment, explaining that after resolution of his patent claim, the issue of common law trademark infringement will still remain. However, plaintiff’s complaint contains only one count, asserting patent infringement. Therefore, he has no common law trademark infringement claim.

Summary Judgment Standard Summary judgment is appropriate when the record reveals “no genuine issue as to any material fact and . . . the moving party is entitled to a judgment as a matter of law.” FED. R . CIV. P . 56(c). “To determine whether these criteria have been met, a court must pierce the boilerplate of the pleadings and carefully review the parties’ submissions to ascertain whether they reveal a trialworthy issue as to any material fact.” Perez v . Volvo Car Corp., 247 F.3d 303, 310 (1st Cir. 2001) (citing Grant’s Dairy- Me., L L C v . Comm’r of M e . Dep’t of Agric., Food & Rural Res., 232 F.3d 8 , 14 (1st Cir. 2000)). When ruling on a party’s motion for summary judgment, the court must “scrutinize the summary judgment record ‘in the light most hospitable to the party opposing summary judgment, indulging all reasonable inferences in that party’s favor.’” Navarro v . Pfizer Corp., 261 F.3d 9 0 , 94 (1st Cir. 1995) (quoting Griggs-Ryan v . Smith, 904 F.2d 1 1 2 , 115 (1st Cir. 1990)).

Background

The ’200 patent was issued on March 2 3 , 1993. It discloses “[a] manual support apparatus attachable to a bedframe for

providing a secure and stable method for a user/patient to transfer into and out of bed independently, and enhance in-bed mobility.” ’200 patent (Def.’s Mot. Summ. J., Ex. A ) , abstract, l l . 1-4.

The ’200 patent has two independent claims (claims one and ten) and eight dependent claims. Claim one reads as follows:

A manual support apparatus attachable to a bedframe comprising:

a planar plate member having outside edges;

two tubular members having internal bores for slidable receipt of a support tube;

a first means to attach said tubular members to said plate member; and

a second means to attach said plate member to said bedframe.

’200 patent, col. 6, l l . 12-20. Claim ten reads as follows:

A manual support apparatus attachable to a bedframe comprising:

a planar plate member having outside edges;

a support tube having two legs;

two tubular members having internal bores for slidable receipt of said support tube;

a first means to attach said tubular members to said plate member; and

a second means to attach said plate member to said bedframe.

’200 patent, col. 6, l l . 48-57. The device disclosed in the ’200 patent is a fixed bed rail that is supported in place along the side of a bed by means of a planar plate member that is bolted or clipped, below both the mattress and box spring, to the bedframe side rail on the side of the bed on which the device is installed.

Based upon their understanding of the ’200 patent (O’Brien Aff. ¶¶ 5 - 8 ) , defendants designed and now market their own manual support apparatus called the “Smart-Rail” (id. ¶ 4 ) . The Smart- Rail is a movable bed rail that may be locked in position parallel to the side of a bed, but which may also be unlocked and swung outward, much like a gate, so that it stands perpendicular to the side of the bed. (O’Brien Aff. ¶ 4 ; Def.’s Mot. Summ. J., Exs. B , C , & D.) Unlike the patented device, which has a planar plate member attached to the underside of the bedframe, the Smart-Rail has a tubular support frame that slides between the box spring and the mattress and that may be lashed, with cloth safety straps, to the bedframe side rail on the side of the bed opposite the side on which the device is installed. (O’Brien Aff. ¶ 7.)

Discussion

Plaintiff moves for summary judgment, arguing that the Smart-Rail literally infringes the ’200 patent because it has: (1) a means for attachment to the bedframe; (2) a planar plate member; (3) two tubular members; and (4) a support tube that slides into the tubular members. Defendants counter that the Smart-Rail does not literally infringe because i t : (1) does not attach to the bedframe; (2) has a tubular support frame rather than a planar plate member; and (3) has only one tubular member, rather than two. Defendants further argue that the Smart-Rail does not infringe under the doctrine of equivalents because: (1) cloth safety straps are not the equivalent of bolts or clips; (2) one tubular member is not the equivalent of two tubular members; and (3) a tubular support frame is not the equivalent of a planar plate member. Because the Smart-Rail has neither a “planar plate member” nor its equivalent, the accused device does not infringe the ’200 patent.

Under the United States Patent Act, “[e]xcept as otherwise provided . . . whoever without authority makes, uses, offers to sell, or sells any patented invention, within the United States

or imports into the United States any patented invention during the term of the patent therefor, infringes the patent.” 35 U.S.C. § 271(a).

An infringement analysis requires two steps:

construction of the claims, to determine their scope and meaning, and comparison of the properly construed claims to the allegedly infringing device or method.

Cybor Corp. v . FAS Techs., Inc., 138 F.3d 1448, 1454 (Fed. Cir. 1998) (en banc). Claim construction . . .

is a matter of law . . . . Lockheed Martin Corp. v .

Space Sys./Loral, Inc., 249 F.3d 1314, 1323 (Fed. Cir.

2001). The comparison of claims to the accused device or method, and the corresponding determination of infringement, whether literal or under the doctrine of equivalents, is a question of fact. Tanabe Seiyaku C o .

v . United State Int’l Trade Comm’n, 109 F.3d 726, 731 (Fed. Cir. 1997).

J & M Corp. v . Harley-Davidson, Inc., 269 F.3d 1360, 1366 (Fed. Cir. 2001) (parallel citations omitted).

I. Claim Construction “It is well-settled that, in interpreting an asserted claim, the court should look first to the intrinsic evidence of record, i.e., the patent itself, including the claims, the specification and, if in evidence, the prosecution history.” Vitronics Corp. v . Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996) (citing Markman v . Westview Instruments, Inc., 52 F.3d 9 6 7 , 979

Free access — add to your briefcase to read the full text and ask questions with AI

Leoutsakos v. Coll’s Hospital Pharm., 2003 DNH 109 (D.N.H. 2003).

2003 DNH 109 (Leoutsakos v. Coll’s Hospital Pharm.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Gonzales
520 U.S. 1 (Supreme Court, 1997)
Perez-De-Munoz v. Volvo Car Corp.
247 F.3d 303 (First Circuit, 2001)
Edmund Mann and Beverly Mann v. United States
904 F.2d 1 (Second Circuit, 1990)
Thomas Quesnel v. Prudential Insurance Company
66 F.3d 8 (First Circuit, 1995)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)